Andrew G. Scarfe
Edmonton, AB T6G1Z2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Patterns of emergency department visits preceding colorectal cancer diagnosis: a population-based study.
Journal: Journal of comparative effectiveness research
Published: February 22, 2022
Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: February 02, 2022
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
Journal: Cancers
Published: September 27, 2021
Real-world Patterns of Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation for Patients With Resected Rectal Adenocarcinoma.
Journal: American journal of clinical oncology
Published: May 31, 2021
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.
Journal: Annals of surgery
Published: October 26, 2017
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.
Journal: British journal of cancer
Published: October 10, 2017
Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.
Journal: British journal of cancer
Published: August 07, 2017
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.
Journal: JAMA oncology
Published: October 14, 2016
Script-theory virtual case: A novel tool for education and research.
Journal: Medical teacher
Published: April 23, 2016
A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.
Journal: Clinical breast cancer
Published: May 22, 2015
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 15, 2014
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.
Journal: Journal of the National Cancer Institute
Published: December 05, 2013
Last Updated: 09/26/2026